Invention Grant
- Patent Title: Application of naringenin and naringin in tumor radiotherapy
-
Application No.: US15743288Application Date: 2016-08-25
-
Publication No.: US10307393B2Publication Date: 2019-06-04
- Inventor: Wei Liang , Chun Ling Zhang , Wen Feng Zeng , Chao Zhang , Luo Yang Wang
- Applicant: INSTITUTE OF BIOPHYSICS CHINESE ACADEMY OF SCIENCES
- Applicant Address: CN Beijing CN Zhumadian
- Assignee: INSTITUTE OF BIOPHYSICS CHINESE ACADEMY OF SCIENCES,TOPFOND PHARMACEUTICAL CO., LTD.
- Current Assignee: INSTITUTE OF BIOPHYSICS CHINESE ACADEMY OF SCIENCES,TOPFOND PHARMACEUTICAL CO., LTD.
- Current Assignee Address: CN Beijing CN Zhumadian
- Agent Gokalp Bayramoglu
- Priority: CN201510404716 20150710
- International Application: PCT/CN2016/096711 WO 20160825
- International Announcement: WO2017/008769 WO 20170119
- Main IPC: A61K31/353
- IPC: A61K31/353 ; A61K31/352 ; A61P35/00 ; A61K45/06 ; A61K31/7048 ; A61K41/00 ; A61N5/10
Abstract:
The present invention provides applications of a small molecular flavonoid compound in preparing a medication for sensitizing/synergizing tumor radiation therapy as well as reducing radioactive damage. The small molecular flavonoid compound can be naringenin, hesperetin, luteolin and apigenin, etc. The medication contains a small molecular flavonoid compound and a plurality of conventional pharmaceutical additives; wherein the small molecular flavonoid compound is an active ingredient.
Public/Granted literature
- US20180200223A1 APPLICATION OF NARINGENIN AND NARINGIN IN TUMOR RADIOTHERAPY Public/Granted day:2018-07-19
Information query
IPC分类:
